G2-checkpoint abrogation in irradiated lymphocytes: A new cytogenetic approach to assess individual radiosensitivity and predisposition to cancer

International Journal of Oncology

Volumn 35, Issue 5, 2009, Pages 1223-1230

  Terzoudi, Georgia I ^a   Hatzi, Vasiliki I ^a   Barszczewska, Katarzyna ^a   Manola, Kalliopi N ^a   Stavropoulou, Chryssa ^a   Angelakis, Philip ^b   Pantelias, Gabriel E ^a  

^a IRRP   (Greece)

^b HYGEIA HOSPITAL   (Greece)

Author keywords

Caffeine; Chromatid breaks; G2 assay; G2 checkpoint abrogation; Individual radiosensitivity; Individual radiosensitivity parameter (IRP); Predisposition to cancer

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER SUSCEPTIBILITY; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; CYTOGENETICS; DNA DAMAGE; DNA REPAIR; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; LYMPHOCYTE; PRIORITY JOURNAL; RADIOSENSITIVITY; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

DNA DAMAGE; G2 PHASE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TECHNIQUES; HEMATOLOGIC TESTS; HUMANS; LYMPHOCYTES; NEOPLASMS; RADIATION TOLERANCE; REPRODUCIBILITY OF RESULTS;

EID: 70449590039     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000439     Document Type: Article

References (48)

1. Bentzen SM: Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother Oncol 43: 121-131, 1997.
2. Andreassen CN, Alsner J and Overgaard J: Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it? Radiother Oncol 64: 131-140, 2002.
3. Burnet NG, Johansen J, Turesson I, Nyman J and Peacock JH: Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation Therapy. Int J Cancer 79: 606-613, 1998.
4. Madani I, De Ruyck K, Goeminne H, De Neve W, Thierens H and Van Meerbeeck J: Predicting risk of radiation-induced lung injury. J Thorac Oncol 2: 864-874, 2007. (Pubitemid 47361031)
5. Dikomey E, Borgmann K, Peacock J and Jung H: Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. Int J Radiat Oncol Biol Phys 56: 1194-1200, 2003. (Pubitemid 36794055)
6. Borgmann K, Hoeller U, Nowack S, et al: Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy. Int J Radiat Oncol Biol Phys 71: 256-264, 2008.
7. Alsner J, Andreassen CN and Overgaard J: Genetic markers for prediction of normal tissue toxicity after radiotherapy. Semin Radiat Oncol 18: 126-135, 2008. (Pubitemid 351296451)
8. Baria K, Warren C, Eden OB, Roberts SA, West CM and Scott D: Chromosomal radiosensitivity in young cancer patients: possible evidence of genetic predisposition. Int J Radiat Biol 78: 341-346, 2002. (Pubitemid 34496886)
9. Baria K, Warren C, Roberts SA, West CM and Scott D: Chromosomal radiosensitivity as a marker of predisposition to common cancers? Br J Cancer 84: 892-896, 2001.
10. Scott D: Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet Genome Res 104: 365-370, 2004. (Pubitemid 38721104)
11. Ho AY, Atencio DP, Peters S, et al: Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. Int J Radiat Oncol Biol Phys 65: 646-655, 2006. (Pubitemid 43795849)
12. Andreassen CN, Alsner J, Overgaard M, Sorensen FB and Overgaard J: Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM - a study based on DNA from formalin-fixed paraffin-embedded tissue samples. Int J Radiat Biol 82: 577-586, 2006. (Pubitemid 44373575)
13. Sanford KK, Parshad R, Gantt R, Tarone RE, Jones GM and Price FM: Factors affecting and significance of G2 chromatin radiosensitivity in predisposition to cancer. Int J Radiat Biol 55: 963-981, 1989. (Pubitemid 19154259)
14. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection. Ann ICRP 28: 1-157, 1998.
15. Borgmann K, Haeberle D, Doerk T, Busjahn A, Stephan G and Dikomey E: Genetic determination of chromosomal radiosensitivities in G0- and G2-phase human lymphocytes. Radiother Oncol 83: 196-202, 2007. (Pubitemid 46776925)
16. Smart V, Curwen GB, Whitehouse CA, Edwards A and Tawn EJ: Chromosomal radiosensitivity: a study of the chromosomal G(2) assay in human blood lymphocytes indicating significant interindividual variability. Mutat Res 528: 105-110, 2003. (Pubitemid 36868998)
17. Vral A, Thierens H, Baeyens A and De Ridder L: Chromosomal aberrations and in vitro radiosensitivity: intra-individual versus inter-individual variability. Toxicol Lett 149: 345-352, 2004. (Pubitemid 38469852)
18. Knight RD, Parshad R, Price FM, Tarone RE and Sanford KK: X-ray-induced chromatid damage in relation to DNA repair and cancer incidence in family members. Int J Cancer 54: 589-593, 1993. (Pubitemid 23188189)
19. Scott D, Barber JB, Spreadborough AR, Burrill W and Roberts SA: Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol 75: 1-10, 1999. (Pubitemid 29057038)
20. Scott D, Spreadborough AR, Jones LA, Roberts SA and Moore CJ: Chromosomal radiosensitivity in G2-phase lymphocytes as an indicator of cancer predisposition. Radiat Res 145: 3-16, 1996. (Pubitemid 26006168)
21. Bryant PE, Gray L, Riches AC, et al: The G2 chromosomal radiosensitivity assay. Int J Radiat Biol 78: 863-866, 2002.
22. Terzoudi GI, Jung T, Hain J, et al: Increased G2 chromosomal radiosensitivity in cancer patients: the role of cdk1/cyclin-B activity level in the mechanisms involved. Int J Radiat Biol 76: 607-615, 2000. (Pubitemid 30345161)
23. Baeyens A, Thierens H, Claes K, et al: Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer 87: 1379-1385, 2002. (Pubitemid 36044311)
24. Lisowska H, Lankoff A, Wieczorek A, et al: Enhanced chromosomal radiosensitivity in peripheral blood lymphocytes of larynx cancer patients. Int J Radiat Oncol Biol Phys 66: 1245-1252, 2006. (Pubitemid 44633533)
25. Parshad R, Price FM, Bohr VA, Cowans KH, Zujewski JA and Sanford KK: Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer 74: 1-5, 1996. (Pubitemid 26231970)
26. Scott D, Barber JB, Levine EL, Burrill W and Roberts SA: Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer 77: 614-620, 1998. (Pubitemid 28059469)
27. Howe OL, Daly PA, Seymour C, Ormiston W, Nolan C and Mothersill C: Elevated G2 chromosomal radiosensitivity in Irish breast cancer patients: a comparison with other studies. Int J Radiat Biol 81: 373-378, 2005. (Pubitemid 41117007)
28. Terzoudi GI and Pantelias GE: Conversion of DNA damage into chromosome damage in response to cell cycle regulation of chromatin condensation after irradiation. Mutagenesis 12: 271-276, 1997.
29. Pantelias GE: Radiation-induced cytogenetic damage in relation to changes in interphase chromosome conformation. Radiat Res 105: 341-350, 1986.
30. Cheng X, Pantelias GE, Okayasu R, Cheong N and Iliakis G: Mitosis-promoting factor activity of inducer mitotic cells may affect radiation yield of interphase chromosome breaks in the premature chromosome condensation assay. Cancer Res 53: 5592-5596, 1993. (Pubitemid 23360254)
31. Terzoudi GI and Pantelias GE: Cytogenetic methods for biodosimetry and risk individualisation after exposure to ionising radiation. Radiat Prot Dosimetry 122: 513-520, 2006.
32. Terzoudi GI, Manola KN, Pantelias GE and Iliakis G: Checkpoint abrogation in G2 compromises repair of chromosomal breaks in ataxia telangiectasia cells. Cancer Res 65: 11292-11296, 2005.
33. Scott D, Hu Q and Roberts SA: Dose-rate sparing for micronucleus induction in lymphocytes of controls and ataxia-telangiectasia heterozygotes exposed to 60Co gamma-irradiation in vitro. Int J Radiat Biol 70: 521-527, 1996. (Pubitemid 26388944)
34. Parshad R, Sanford KK and Jones GM: Chromatid damage induced by fluorescent light during G2 phase in normal and Gardner syndrome fibroblasts. Interpretation in terms of deficient DNA repair. Mutat Res 151: 57-63, 1985.
35. Parshad R, Gantt R, Sanford KK and Jones GM: Chromosomal radiosensitivity of human tumor cells during the G2 cell cycle period. Cancer Res 44: 5577-5582, 1984. (Pubitemid 15183560)
36. Sanford KK, Parshad R, Price FM, et al: Enhanced chromatid damage in blood lymphocytes after G2 phase x irradiation, a marker of the ataxia-telangiectasia gene. J Natl Cancer Inst 82: 1050-1054, 1990. (Pubitemid 20204977)
37. Papworth R, Slevin N, Roberts SA and Scott D: Sensitivity to radiation-induced chromosome damage may be a marker of genetic predisposition in young head and neck cancer patients. Br J Cancer 84: 776-782, 2001. (Pubitemid 32275650)
38. Scott D, Spreadborough A, Levine E and Roberts SA: Genetic predisposition in breast cancer. Lancet 344: 1444, 1994.
39. Terzoudi GI, Singh SK, Pantelias GE and Iliakis G: Premature chromosome condensation reveals DNA-PK independent pathways of chromosome break repair. Int J Oncol 33: 871-879, 2008.
40. Iliakis G, Wang H, Perrault AR, et al: Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet Genome Res 104: 14-20, 2004. (Pubitemid 38721048)
41. Koch K, Wrona A, Dikomey E and Borgmann K: Impact of homologous recombination on individual cellular radiosensitivity. Radiother Oncol 90: 265-272, 2009.
42. Natarajan AT and Palitti F: DNA repair and chromosomal alterations. Mutat Res 657: 3-7, 2008.
43. Wu W, Wang M, Mussfeldt T and Iliakis G: Enhanced use of backup pathways of NHEJ in G2 in Chinese hamster mutant cells with defects in the classical pathway of NHEJ. Radiat Res 170: 512-520, 2008.
44. Pawlik TM and Keyomarsi K: Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59: 928-942, 2004. (Pubitemid 38834285)
45. Foray N, Arlett CF and Malaise EP: Underestimation of the small residual damage when measuring DNA double-strand breaks (DSB): is the repair of radiation-induced DSB complete? Int J Radiat Biol 75: 1589-1595, 1999.
46. Chen MF, Lin CT, Chen WC, et al: The sensitivity of human mesenchymal stem cells to ionizing radiation. Int J Radiat Oncol Biol Phys 66: 244-253, 2006. (Pubitemid 44175661)
47. Natarajan AT, Obe G and Dulout FN: The effect of caffeine post treatment on X-ray induced chromosomal aberrations in human blood lymphocytes in vitro. Hum Genet 54: 183-189, 1980. (Pubitemid 10111812)
48. Natarajan AT, Meijers M, van Zeeland AA and Simons JW: Attempts to detect ataxia-telangiectasia (AT) heterozygotes by cytogenetical techniques. Cytogenet Cell Genet 33: 145-151, 1982. (Pubitemid 12038938)